Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences
NRG Oncology
Institut Cancerologie de l'Ouest
M.D. Anderson Cancer Center
Brigham and Women's Hospital
Stanford University
Wake Forest University Health Sciences
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
Washington University School of Medicine
University of Florida
Memorial Sloan Kettering Cancer Center
Essen Biotech
Essen Biotech
University of Nebraska
M.D. Anderson Cancer Center
University of Southern California
The Netherlands Cancer Institute
Ohio State University Comprehensive Cancer Center
Mayo Clinic
The First Affiliated Hospital of Xinxiang Medical College
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine
UNC Lineberger Comprehensive Cancer Center
Young Adult Survivors United
Virginia Commonwealth University
Hadassah Medical Organization
British Columbia Cancer Agency
Institut Curie
Mayo Clinic
Washington University School of Medicine
University of Florida
Milton S. Hershey Medical Center
Baylor College of Medicine
University of Virginia
University Health Network, Toronto
Duke University
NRG Oncology
Mayo Clinic
Columbia University
University of Arizona
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
N.N. Petrov National Medical Research Center of Oncology
Region Skane
University of Alberta